Mostrar el registro sencillo del ítem
Evolution of the prevalence of polypharmacy in a poor population of the colombian caribbean during 2019-2021
dc.contributor.author | Gamero, K | spa |
dc.contributor.author | Alvis, J | spa |
dc.contributor.author | Fernandez Mercado, JC | spa |
dc.contributor.author | Paz Wilchez, J | spa |
dc.contributor.author | Alvis-Guzmán, Nelson | spa |
dc.coverage.temporal | 2019-2021 | spa |
dc.date.accessioned | 2022-07-18T13:11:34Z | |
dc.date.available | 2023 | |
dc.date.available | 2022-07-18T13:11:34Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | K Gamero, J Alvis, JC Fernandez Mercado, J Paz Wilchez, N Alvis Guzman, EPH90 Evolution of the Prevalence of Polypharmacy in a Poor Population of the Colombian Caribbean during 2019-2021, Value in Health, Volume 25, Issue 7, Supplement, 2022, Page S451, ISSN 1098-3015, https://doi.org/10.1016/j.jval.2022.04.842. | spa |
dc.identifier.issn | 1098-3015 | spa |
dc.identifier.uri | https://hdl.handle.net/11323/9375 | spa |
dc.description.abstract | Today, polypharmacy represents one of the major concerns of health systems in the world due to the risks associated with the inappropriate use of drugs and its impact on growing pharmaceutical spending. The aim of this study is to estimate the variation in the prevalence of polypharmacy during 2019-2021. Cross sectional descriptive study of polymedicated patients during 2019-2021 was developed. Data was extracted from the individual outpatient dispense records from a health insurance company in Colombia. Polypharmacy was defined as mild, moderate and severe when patients consumed among 5-9, 10-15 and ≥15 medications in at least a continuous month throughout the years 2019-2021. Prevalence and characteristics as age and gender in polymedicated patients were estimated. 429.967 patients were identified as consumers of medicines in 2021. The overall prevalence of polymedication was 29.2%, 3 pp. higher than 2019. The mean number of medications per patient was 6.79± 2.1 in 2019 and 6.93± 0.04 in 2021. Mild polymedication was about 26.9%, moderate 2.1% and severe 0.2% in 2021, 1.6pp., 0.9pp. and 0.1pp. higher than 2019 respectively. The average age of a patient in 2021 with mild, moderate and severe polymedication was 56.15 (CI95%: 56.1-56.2), 64.5 (CI 95%: The observed increase in polypharmacy could be influenced by the increase in the prescription rate and by a less and less interaction between the different prescribers. These, represent significant risks to the health of patients and can significantly impact pharmaceutical spending. This study contributes to decision-making on health risk management and drug consumption control, especially in the elderly population. | eng |
dc.format.extent | 1 página | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | |
dc.publisher | Elsevier Ltd. | spa |
dc.rights | © 2022 Published by Elsevier Inc. | spa |
dc.rights | Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | spa |
dc.title | Evolution of the prevalence of polypharmacy in a poor population of the colombian caribbean during 2019-2021 | eng |
dc.type | Artículo de revista | spa |
dc.identifier.url | https://doi.org/10.1016/j.jval.2022.04.842 | spa |
dc.source.url | https://www.valueinhealthjournal.com/article/S1098-3015(22)01043-9/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301522010439%3Fshowall%3Dtrue#relatedArticles | spa |
dc.rights.accessrights | info:eu-repo/semantics/embargoedAccess | spa |
dc.identifier.doi | 10.1016/j.jval.2022.04.842 | spa |
dc.identifier.eissn | 1524-4733 | spa |
dc.coverage.country | Colombia | |
dc.identifier.instname | Corporación Universidad de la Costa | spa |
dc.identifier.reponame | REDICUC - Repositorio CUC | spa |
dc.identifier.repourl | https://repositorio.cuc.edu.co/ | spa |
dc.publisher.place | United Kingdom | spa |
dc.relation.ispartofjournal | Value in Health | spa |
dc.subject.proposal | Polypharmacy | eng |
dc.subject.proposal | Colombian Caribbean | eng |
dc.subject.proposal | Pharmaceutical | eng |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | spa |
dc.type.version | info:eu-repo/semantics/draft | spa |
dc.relation.citationstartpage | 7 | spa |
dc.relation.citationissue | 25 | spa |
dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
dc.rights.coar | http://purl.org/coar/access_right/c_f1cf | spa |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos científicos [3156]
Artículos de investigación publicados por miembros de la comunidad universitaria.